Canonical ingredient

insulin lispro

INSULIN LISPRO

24 linked products

Official identifiers

CAS 133107-64-9 ChEBI CHEBI:232799 InChI InChI=1S/C158H234N40O42S2.C99H155N25O35S4/c1-79(2)57-104(181-131(213)86(15)173-136(218)102(50-53-125(211)212)179-152(234)127(84(11)12)194-148(230)107(60-82(7)8)184-145(227)113(67-95-70-166-78-172-95)189-150(232)115(74-199)176-123(208)73-170-134(216)116(75 InChIKey WNRQPCUGRUFHED-DETKDSODSA-N SMILES [H][C@](C)(O)[C@]([H])(/N=C(\O)[C@]([H])(CS)/N=C(\O)[C@]([H])(CS)/N=C(\O)[C@]([H])(CCC(=N)O)/N=C(\O)[C@]([H])(CCC(=O)O)/N=C(\O)[C@@]([H])(/N=C(\O)[C@@]([H])(/N=C(\O)CN)[C@@]([H])(C)CC)C(C)C)/C(O)=N/[C@@]([H])(CO)/C(O)=N/[C@]([H])(/C(O)=N/[C@@]([H])(CS)/C(

Names and synonyms

insulin lispro (en)
Insuline lispro (fr)

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.